Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine brokerages that are covering the company, MarketBeat reports ...

U.S. President Donald Trump's tariffs on aluminium are more likely to be part of a bargaining strategy than a long-term ...

Super Micro Computer's ambitious $40B revenue forecast for FY 2026 boosts stock. Click here to find out why I am neutral on ...

Gio says the Jets made the right decision in not bringing back Aaron Rodgers next season, as a culture change is needed within the organization.

Celestica's valuation is now more aligned with its growth, leaving a limited margin of safety; a 15-20% dip would make it ...

A new meme coin on the Solana blockchain is about to make its debut, and whispers of massive gains are … Continue reading ...

Reddit forecast for Q3 revenue was above estimate indicating a rebound in digital ad market, drawing more advertisers to its ...

Imagine turning a mere $100 into a life-changing $1 million by April 2025 through three rapidly ascending cryptocurrencies.

Coins like PEPE have less short-term potential. DOGEN, designed for those seeking luxury and success, is expected to grow 700 ...

market downturn, a new contender is capturing attention. Dogen is poised to make a remarkable debut, with experts predicting ...

SG Americas Securities LLC cut its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 18.1% in the fourth quarter, Holdings Channel.com reports. The institutional investor ...

The match begins with two wrestlers in the ring and every two minutes, a new participant comes out to join the match. In past ...